Abstract |
The effects of the administration of metoclopramide, cisapride and SR-17 on memory processes were evaluated in the mouse passive avoidance test. The administration of dicyclomine (0.1-3 mg kg-1 i.p.), immediately after termination of the training session, produced a dose-dependent amnesic effect. Metoclopramide (1-5 mg kg-1 i.p.), cisapride (0.5-2 mg kg-1 i.p.) and SR-17 (1-10 mg kg-1 i.p.), administered 20 min before the training session, prevented dicyclomine-induced amnesia. In the same experimental conditions piracetam (30 mg kg-1 i.p.), physostigmine (0.2 mg kg-1 i.p.) and CGP 35348 (100 mg kg-1 i.p.) prevented dicyclomine amnesia. At the highest effective doses, none of the drugs impaired motor coordination, as revealed by the rota-rod test, nor did they modify spontaneous motility, as revealed by the Animex test. These results suggest that metoclopramide, cisapride and SR-17 play an important role in the modulation of memory processes. On these bases, these compounds could be useful in the treatment of cognitive deficits.
|
Authors | N Galeotti, C Ghelardini, E Teodori, F Gualtieri, A Bartolini |
Journal | Pharmacological research
(Pharmacol Res)
Vol. 36
Issue 1
Pg. 59-67
(Jul 1997)
ISSN: 1043-6618 [Print] Netherlands |
PMID | 9368916
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Benzofurans
- Bridged Bicyclo Compounds
- Dopamine Antagonists
- Muscarinic Antagonists
- Piperidines
- Serotonin Antagonists
- Serotonin Receptor Agonists
- endo 8-methyl-8-azabicyclo(3.2.1)octan-3-yl benzofurane-3-carboxylate
- Dicyclomine
- Metoclopramide
- Cisapride
|
Topics |
- Amnesia
(chemically induced, prevention & control)
- Animals
- Avoidance Learning
(drug effects)
- Behavior, Animal
(drug effects)
- Benzofurans
(pharmacology)
- Bridged Bicyclo Compounds
(pharmacology)
- Cisapride
- Dicyclomine
(pharmacology)
- Dopamine Antagonists
(pharmacology)
- Dose-Response Relationship, Drug
- Male
- Memory
(drug effects)
- Metoclopramide
(pharmacology)
- Mice
- Motor Activity
(drug effects)
- Muscarinic Antagonists
(pharmacology)
- Piperidines
(pharmacology)
- Serotonin Antagonists
(pharmacology)
- Serotonin Receptor Agonists
(pharmacology)
|